Adipotide
A peptidomimetic that targets prohibitin on the vasculature feeding white adipose tissue, triggering apoptosis of fat-supplying blood vessels and rapid fat loss in animal models. Cross-shopped with fat-loss compounds like AOD-9604 and the GLP-1s. Evidence is limited to rodent and non-human-primate studies with documented kidney toxicity signals; there are no human trials, so it is experimental and its safety in people is unknown.
Research Evidence
Clinical evidence not projected yet.
Anecdotal efficacy
Community efficacy aggregate not available or did not pass volume floor
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Symptom-relevant clinical or community evidence has not been captured for this peptide yet.
Price
No live vendor pricing captured for this peptide yet.
Dosing & Protocol
Dosing protocol not projected for this peptide yet.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
Forum threadLive community discussion for Adipotide, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.